ClinicalTrials.govpublic full text
The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
non-small cell lung cancer (nsclc, locally advanced or metastatic, second-line, andamertinib, anlotinib, third-generation egfr-tki, non-small cell lung cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 833648
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.